Gain Scores, ANCOVA, and the Model Behind the Number

How Analytic Choices Shape Treatment Effect Estimates

This note is coming soon. It is Part 3 of a three-part series on Compass Pathways’ COMP360 psilocybin program for treatment-resistant depression.

Read Part 1: What Does ‘Clinically Meaningful’ Mean? now.